Literature DB >> 22042244

Mucinous cystic neoplasms of the pancreas: definition of preoperative imaging criteria for high-risk lesions.

Yann Le Baleur1, Anne Couvelard, Marie Pierre Vullierme, Alain Sauvanet, Pascal Hammel, Vinciane Rebours, Frédérique Maire, Olivia Hentic, Alain Aubert, Philippe Ruszniewski, Philippe Lévy.   

Abstract

BACKGROUND/AIM: Pancreatic mucinous cystic neoplasms (MCN) are premalignant lesions whose natural history is poorly known. Whether the dysplasia grade might be determined with precision by preoperative clinical and imaging criteria is not known. We aimed to determine if CT scan data might be useful to predict the grade of dysplasia in a series of 60 histologically proven MCN.
METHODS: All consecutive patients who were operated on with pathological confirmation of MCN were included. Careful CT scan evaluation was reviewed without knowledge of pathological results. Imaging and pathological results were correlated.
RESULTS: Sixty patients (59 females) were included. Low- and intermediate-grade dysplasias were identified in 47 and 3 patients (benign MCN), respectively, and high-grade dysplasia and invasive carcinoma in 7 and 3 patients (malignant MCN), respectively. Patients with benign lesions were significantly younger. None of the studied clinical data were statistically different to distinguish benign and malignant MCN, except age (42 vs. 48 years, p < 0.05). Only maximal diameter and mural nodules on CT scan were significantly more frequent in the malignant group. No malignant MCN had a maximal diameter <40 mm. At a 40-mm threshold, the sensitivity and specificity of the maximal diameter to diagnose malignant MCN were 100 and 54%, respectively. Mural nodules seen on CT scan were confirmed in all cases but one upon pathological examination of the surgical specimen. The sensitivity and specificity of the presence of a mural nodule seen on CT scan for the diagnosis of a malignant lesion were 100 and 98%, respectively.
CONCLUSION: Preoperative CT scan detection of a mural nodule within a cystic pancreatic neoplasm suggestive of MCN strongly suggests malignancy. A diameter <40 mm is associated with no risk of malignancy.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2011        PMID: 22042244     DOI: 10.1159/000332041

Source DB:  PubMed          Journal:  Pancreatology        ISSN: 1424-3903            Impact factor:   3.996


  16 in total

Review 1.  [Cystic pancreatic tumors: diagnostics and new biomarkers].

Authors:  A W Berger; T Seufferlein; A Kleger
Journal:  Chirurg       Date:  2017-11       Impact factor: 0.955

Review 2.  Pancreatic Cysts and Guidelines.

Authors:  James J Farrell
Journal:  Dig Dis Sci       Date:  2017-05-20       Impact factor: 3.199

3.  Association of Preoperative Risk Factors With Malignancy in Pancreatic Mucinous Cystic Neoplasms: A Multicenter Study.

Authors:  Lauren M Postlewait; Cecilia G Ethun; Mia R McInnis; Nipun Merchant; Alexander Parikh; Kamran Idrees; Chelsea A Isom; William Hawkins; Ryan C Fields; Matthew Strand; Sharon M Weber; Clifford S Cho; Ahmed Salem; Robert C G Martin; Charles Scoggins; David Bentrem; Hong J Kim; Jacquelyn Carr; Syed Ahmad; Daniel E Abbott; Gregory C Wilson; David A Kooby; Shishir K Maithel
Journal:  JAMA Surg       Date:  2017-01-01       Impact factor: 14.766

Review 4.  Imaging modalities for characterising focal pancreatic lesions.

Authors:  Lawrence Mj Best; Vishal Rawji; Stephen P Pereira; Brian R Davidson; Kurinchi Selvan Gurusamy
Journal:  Cochrane Database Syst Rev       Date:  2017-04-17

5.  Pancreatic mucinous cystic neoplasms located in the distal pancreas: a multicenter study.

Authors:  Jose M Ramia; Juan Del Rio Martín; Gerardo Blanco-Fernández; Miguel Cantalejo-Diaz; Fernando Pardo; Elena Muñoz-Forner; Alberto Carabias; Alba Manuel-Vazquez; Pedro J Hernández-Rivera; Isabel Jaén-Torrejimeno; Helga K Kälviäinen-Mejia; Fernando Rotellar-Sastre; Marina Garcés-Albir; Raquel Latorre; Texell Longoria-Dubocq; Noelia De Armas-Conde; Alejandro Serrablo-Requejo; Sara Esteban Gordillo; Luis Sabater; Mario Serradilla-Martín
Journal:  Gland Surg       Date:  2022-05

6.  One of the multifocal intraductal papillary mucinous neoplasms with the clinical characteristics of mucinous cystic neoplasm.

Authors:  Tatsuo Hata; Naoaki Sakata; Fuyuhiko Motoi; Michiaki Unno
Journal:  BMJ Case Rep       Date:  2013-02-18

Review 7.  Pancreatic ductal adenocarcinoma: risk factors, screening, and early detection.

Authors:  Andrew E Becker; Yasmin G Hernandez; Harold Frucht; Aimee L Lucas
Journal:  World J Gastroenterol       Date:  2014-08-28       Impact factor: 5.742

8.  Pancreatic mucinous cystoadenomas and cystoadenocarcinomas: differential diagnosis by means of MRI.

Authors:  Valerio Di Paola; Riccardo Manfredi; Sara Mehrabi; Nicolò Cardobi; Emanuele Demozzi; Salvatore Belluardo; Roberto Pozzi Mucelli
Journal:  Br J Radiol       Date:  2015-11-03       Impact factor: 3.039

Review 9.  Elevating pancreatic cystic lesion stratification: Current and future pancreatic cancer biomarker(s).

Authors:  Joseph Carmicheal; Asish Patel; Vipin Dalal; Pranita Atri; Amaninder S Dhaliwal; Uwe A Wittel; Mokenge P Malafa; Geoffrey Talmon; Benjamin J Swanson; Shailender Singh; Maneesh Jain; Sukhwinder Kaur; Surinder K Batra
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2019-10-30       Impact factor: 10.680

Review 10.  Differential Diagnosis of Cystic Pancreatic Lesions Including the Usefulness of Biomarkers.

Authors:  Philippe Lévy; Vinciane Rebours
Journal:  Viszeralmedizin       Date:  2015-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.